Shareholders Dan Venture Capital and Zhang Xin of Joint Pharmaceutical intend to jointly reduce their shareholding by no more than 3%; Shareholders holding more than 5% of Anlian Ruishi's shares and their concerted actions plan to reduce their shareholding by a total of no more than 2.93% of the company's shares; Shareholders Changcheng and Junlian Chengyu of Kangzhong Medical intend to jointly reduce their shareholding by no more than 2%; China Energy Construction indicates that 18.206 billion shares will be restricted from trading on September 30; *ST Yinjiang's stocks are subject to additional special treat risk warnings; There is still uncertainty in the equity transfer of Yonghui Superstores; ST Baili's stocks are subject to additional special treat risk warnings.
